KFDA to introduce Good Review Practice

The Korea Food and Drug Administration unveiled its plan to introduce a new good review practice (GRP) system as part of its efforts to ensure transparency, consistence and specialty in screening drug-related applications, adding that such introduction will contribute to pharmaceutical exports in the long run.

The legal issues and scope following the disclosure of the GRP-based screening res...